Search Results
Are hypomethylating agents useful in preventing relapse in AML and MDS?
What are hypomethylating agents and when are they used for MDS?
Hypomethylating agents in MDS and AML
Intervening on time: how hypomethylating agents can prevent transition to AML
Preventing relapse post-transplant in AML and MDS?
Hypomethylating agents for relapsed and refractory acute myeloid leukaemia
Anti-TIM-3 antibody sabatolimab + hypomethylating agents for high-risk MDS & AML
Prof. C Craddock | EBMT 2018 | Can hypomethylating agents prevent post-transplant relapse in AML?
What are the advantages of mechanism-based therapies to prevent AML relapse?
Management of relapse following alloHSCT in patients with AML and MDS
Hypomethylating Agents for AML
AML Treatment Challenges Who, When, and How
